Since the beginning of 2022, EUPATI has been a part of the 360° HTA Patient Involvement project, together with patients’ organisations, industry partners and small-medium sized compagnies. The 360° HTA Patient Involvement project is funded by the European Federation of Pharmaceutical Industries and Associations aims to research the current methods and processes for patient involvement in HTA in Europe and analyse how they are perceived by the different stakeholders.
EUPATI’s role in the project is contributing to the survey on the role of patient engagement in HTA and gather responses. For this, EUPATI works closely with EUPATI Fellows who will be contributing to and shaping the development of the project.
We would like to ask persons from all stakeholder groups (patients, carers, industry, academics, healthcare providers, HTA agencies) who have experienced patient involvement in HTA in any European country to share their experiences in a 20-30 min survey. The survey has been co-created by patient organisations and HTA-experts, it is available in six languages (English, French, German, Italian, Spanish, Polish) and is completely anonymous. We will be sharing aggregated survey results and insights on our website as well as through our social media channels and dedicated webinars or you can register to receive the report.
Thank you very much for supporting patient engagement in HTA – your views matter and we are grateful for your continuous support!
Answer the survey now:
Date posted: May 1, 2022